ABELCET

Brand name authorized in: Brazil Canada Spain France Netherlands Poland United Kingdom United States

Active ingredients

The drug ABELCET contains one active pharmaceutical ingredient (API):

1 Amphotericin B
UNII 7XU7A7DROE - AMPHOTERICIN B

Amphotericin B is a macrocyclic, polyene antifungal antibiotic produced by Streptomyces nodosus. The molecule is thought to act by binding to sterols in the fungal cell membrane, with a resulting change in membrane permeability, allowing leakage of a variety of small molecules.

Read about Amphotericin B

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
Amphotericin B
J Antiinfectives for systemic use → J02 Antimycotics for systemic use → J02A Antimycotics for systemic use → J02AA Antibiotics
Discover more medicines within J02AA01

Unique identifiers

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
BR
Câmara de Regulação do Mercado de Medicamentos
Identifier(s): 525500605111312
CA
Health Products and Food Branch
Identifier(s): 02231590
ES
Centro de información online de medicamentos de la AEMPS
Identifier(s): 60945
FR
Base de données publique des médicaments
Identifier(s): 66207341
GB
Medicines & Healthcare Products Regulatory Agency
Identifier(s): 213026, 79837
NL
Z-Index G-Standaard
Identifier(s): 15016757
NL
Z-Index G-Standaard, PRK
Identifier(s): 38849
PL
Rejestru Produktów Leczniczych
Identifier(s): 100111765
US
FDA, National Drug Code
Identifier(s): 57665-101